Change-point detection is a challenging problem that has a number of applications across various real-world domains. The primary objective of CPD is to identify specific time points where the underlying system undergoes transitions between different states, each characterized by its distinct data distribution. Precise identification of change points in time series omics data can provide insights into the dynamic and temporal characteristics inherent to complex biological systems. Many change-point detection methods have traditionally focused on the direct estimation of data distributions. However, these approaches become unrealistic in high-dimensional data analysis. Density ratio methods have emerged as promising approaches for change-point detection since estimating density ratios is easier than directly estimating individual densities. Nevertheless, the divergence measures used in these methods may suffer from numerical instability during computation. Additionally, the most popular -relative Pearson divergence cannot measure the dissimilarity between two distributions of data but a mixture of distributions. To overcome the limitations of existing density ratio-based methods, we propose a novel approach called the Pearson-like scaled-Bregman divergence-based (PLsBD) density ratio estimation method for change-point detection. Our theoretical studies derive an analytical expression for the Pearson-like scaled Bregman divergence using a mixture measure. We integrate the PLsBD with a kernel regression model and apply a random sampling strategy to identify change points in both synthetic data and real-world high-dimensional genomics data of Drosophila. Our PLsBD method demonstrates superior performance compared to many other change-point detection methods.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138604 | PMC |
http://dx.doi.org/10.3390/stats7020028 | DOI Listing |
J Comput Biol
January 2025
Department of Statistics and Actuarial Science, Simon Fraser University, Burnaby, BC, Canada.
Maintaining homeostasis, the regulation of internal physiological parameters, is essential for health and well-being. Deviations from optimal levels, or 'sweet spots,' can lead to health deterioration and disease. Identifying biomarkers with sweet spots requires both change-point detection and variance effect analysis.
View Article and Find Full Text PDFBiometrics
January 2025
Department of Statistics and Data Science, National University of Singapore, Singapore 117546, Singapore.
Pharmacogenomics stands as a pivotal driver toward personalized medicine, aiming to optimize drug efficacy while minimizing adverse effects by uncovering the impact of genetic variations on inter-individual outcome variability. Despite its promise, the intricate landscape of drug metabolism introduces complexity, where the correlation between drug response and genes can be shaped by numerous nongenetic factors, often exhibiting heterogeneity across diverse subpopulations. This challenge is particularly pronounced in datasets such as the International Warfarin Pharmacogenetic Consortium (IWPC), which encompasses diverse patient information from multiple nations.
View Article and Find Full Text PDFEBioMedicine
January 2025
MGH Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Electronic address:
Background: The ovarian cancer (OC) preclinical detectable phase (PCDP), defined as the interval during which cancer is detectable prior to clinical diagnosis, remains poorly characterised. We report exploratory analyses from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Methods: In UKCTOCS between Apr-2001 and Sep-2005, 101,314 postmenopausal women were randomised to no screening (NS) and 50,625 to annual multimodal screening (MMS) (until Dec-2011) using serum CA-125 interpreted by the Risk of Ovarian Cancer Algorithm (ROCA).
J Cardiothorac Surg
January 2025
Princess Alexandra Hospital, Brisbane, QLD, Australia.
Background: Individual surgeons' learning curves are a crucial factor impacting patient outcomes. While many studies investigate procedure-specific learning curves, very few carried out a longitudinal analysis of individual cardiac surgeons over the course of their career. Given the evolving landscape of cardiac surgery with the introduction of transcatheter and robotic procedures, a contemporary evaluation of the cardiac surgical learning curve is justified and a method of personal performance monitoring is proposed in this study.
View Article and Find Full Text PDFAnesth Analg
December 2024
From the Department of Anesthesiology, Cleveland Clinic, Cleveland, Ohio.
Background: Both intraoperative hypotension and excessive fluid administration can lead to detrimental perioperative complications. However, how much fluid is considered excessive and how is intraoperative hypotension related to major postoperative complications?
Methods: We conducted a single-center retrospective cohort study in 6243 patients undergoing complex spine surgery at the Cleveland Clinic Foundation between 2012 and 2022 and studied the relationship between intraoperative net fluid administration and intraoperative hypotension with major postoperative complications. The primary outcome was a collapsed composite of postoperative complications including acute kidney injury (AKI), myocardial infarction (MI), stroke, and intensive care unit (ICU) admissions.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!